Literature DB >> 15192636

Mild variant of nonketotic hyperglycinemia with typical neonatal presentations: mutational and in vitro expression analyses in two patients.

Shigeo Kure1, Akiko Ichinohe, Kanako Kojima, Kenichi Sato, Zenro Kizaki, Fumio Inoue, Chutaro Yamanaka, Yoichi Matsubara.   

Abstract

In neonatal-onset nonketotic hyperglycinemia, severe psychomotor retardation is the expected uniform outcome. We report two patients with typical neonatal presentation who showed far better developmental outcomes. The in vitro expression analysis of the identified GLDC mutations revealed considerable residual enzyme activity, suggesting prognostic and enzymatic heterogeneity even in neonatal-onset nonketotic hyperglycinemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192636     DOI: 10.1016/j.jpeds.2004.02.044

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.

Authors:  J L K Van Hove; K Vande Kerckhove; J B Hennermann; V Mahieu; P Declercq; S Mertens; M De Becker; P S Kishnani; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Prediction of long-term outcome in glycine encephalopathy: a clinical survey.

Authors:  Julia B Hennermann; Jeanne-Marie Berger; Ulrike Grieben; Gunter Scharer; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2011-10-15       Impact factor: 4.982

3.  Genetic heterogeneity of the GLDC gene in 28 unrelated patients with glycine encephalopathy.

Authors:  C Conter; M O Rolland; D Cheillan; V Bonnet; I Maire; R Froissart
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

4.  Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia.

Authors:  Junko Kanno; Tim Hutchin; Fumiaki Kamada; Ayumi Narisawa; Yoko Aoki; Yoichi Matsubara; Shigeo Kure
Journal:  J Med Genet       Date:  2007-03       Impact factor: 6.318

5.  Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia.

Authors:  Michael A Swanson; Curtis R Coughlin; Gunter H Scharer; Heather J Szerlong; Kendra J Bjoraker; Elaine B Spector; Geralyn Creadon-Swindell; Vincent Mahieu; Gert Matthijs; Julia B Hennermann; Derek A Applegarth; Jennifer R Toone; Suhong Tong; Kristina Williams; Johan L K Van Hove
Journal:  Ann Neurol       Date:  2015-08-10       Impact factor: 10.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.